34
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Structures and General Transport Mechanisms by the Major Facilitator Superfamily (MFS)

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The major facilitator superfamily (MFS) is the largest known superfamily of secondary active transporters. MFS transporters are responsible for transporting a broad spectrum of substrates, either down their concentration gradient or uphill using the energy stored in the electrochemical gradients. Over the last 10 years, more than a hundred different MFS transporter structures covering close to 40 members have provided an atomic framework for piecing together the molecular basis of their transport cycles. Here, we summarize the remarkable promiscuity of MFS members in terms of substrate recognition and proton coupling as well as the intricate gating mechanisms undergone in achieving substrate translocation. We outline studies that show how residues far from the substrate binding site can be just as important for fine-tuning substrate recognition and specificity as those residues directly coordinating the substrate, and how a number of MFS transporters have evolved to form unique complexes with chaperone and signaling functions. Through a deeper mechanistic description of glucose (GLUT) transporters and multidrug resistance (MDR) antiporters, we outline novel refinements to the rocker-switch alternating-access model, such as a latch mechanism for proton-coupled monosaccharide transport. We emphasize that a full understanding of transport requires an elucidation of MFS transporter dynamics, energy landscapes, and the determination of how rate transitions are modulated by lipids.

          Related collections

          Most cited references406

          • Record: found
          • Abstract: found
          • Article: not found

          Pattern recognition receptors and inflammation.

          Infection of cells by microorganisms activates the inflammatory response. The initial sensing of infection is mediated by innate pattern recognition receptors (PRRs), which include Toll-like receptors, RIG-I-like receptors, NOD-like receptors, and C-type lectin receptors. The intracellular signaling cascades triggered by these PRRs lead to transcriptional expression of inflammatory mediators that coordinate the elimination of pathogens and infected cells. However, aberrant activation of this system leads to immunodeficiency, septic shock, or induction of autoimmunity. In this Review, we discuss the role of PRRs, their signaling pathways, and how they control inflammatory responses. 2010 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Membrane transporters in drug development.

            Membrane transporters can be major determinants of the pharmacokinetic, safety and efficacy profiles of drugs. This presents several key questions for drug development, including which transporters are clinically important in drug absorption and disposition, and which in vitro methods are suitable for studying drug interactions with these transporters. In addition, what criteria should trigger follow-up clinical studies, and which clinical studies should be conducted if needed. In this article, we provide the recommendations of the International Transporter Consortium on these issues, and present decision trees that are intended to help guide clinical studies on the currently recognized most important drug transporter interactions. The recommendations are generally intended to support clinical development and filing of a new drug application. Overall, it is advised that the timing of transporter investigations should be driven by efficacy, safety and clinical trial enrolment questions (for example, exclusion and inclusion criteria), as well as a need for further understanding of the absorption, distribution, metabolism and excretion properties of the drug molecule, and information required for drug labelling.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Understanding the diversity of membrane lipid composition

                Bookmark

                Author and article information

                Journal
                Chem Rev
                Chem Rev
                cr
                chreay
                Chemical Reviews
                American Chemical Society
                0009-2665
                1520-6890
                22 April 2021
                12 May 2021
                : 121
                : 9 , Transporters, Porins, and Efflux Pumps
                : 5289-5335
                Affiliations
                []Department of Biochemistry and Biophysics, Stockholm University , SE 106 91 Stockholm, Sweden
                []Center of Structural and Cell Biology in Medicine, Institute of Biochemistry, University of Lübeck , D-23538, Lübeck, Germany
                [§ ]Structural Biology Research Center, Institute of Materials Structure Science, High Energy Accelerator Research Organization (KEK) , Oho 1-1, Tsukuba, Ibaraki 305-0801, Japan
                Author notes
                [* ]M.T.: email, mikio.tanabe@ 123456kek.jp .
                [* ]D.D.: email, david.drew@ 123456dbb.su.se .
                Author information
                http://orcid.org/0000-0002-4096-6075
                Article
                10.1021/acs.chemrev.0c00983
                8154325
                33886296
                c6d33801-7e88-4285-b30e-0c4916574aa8
                © 2021 The Authors. Published by American Chemical Society

                Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works ( https://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 09 September 2020
                Funding
                Funded by: European Molecular Biology Organization, doi 10.13039/100004410;
                Award ID: ALTF 33-2019
                Funded by: Novo Nordisk Fonden, doi 10.13039/501100009708;
                Award ID: NA
                Funded by: Vetenskapsrådet, doi 10.13039/501100004359;
                Award ID: NA
                Funded by: Knut och Alice Wallenbergs Stiftelse, doi 10.13039/501100004063;
                Award ID: NA
                Funded by: Japan Society for the Promotion of Science, doi 10.13039/501100001691;
                Award ID: 19H03186
                Funded by: H2020 European Research Council, doi 10.13039/100010663;
                Award ID: NA
                Funded by: Japan Agency for Medical Research and Development, doi 10.13039/100009619;
                Award ID: JP20am0101071
                Categories
                Review
                Custom metadata
                cr0c00983
                cr0c00983

                Chemistry
                Chemistry

                Comments

                Comment on this article